AI-CVD vs VitalConnect VitalPatch

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by HeartLung AI
VS
by VitalConnect

AI Verdict

AI-CVD is an AI-powered imaging platform that performs opportunistic screening for cardiovascular diseases using existing CT scans, focusing on identifying hidden risks through retrospective analysis. In contrast, VitalConnect VitalPatch is a wearable biosensor system for real-time, continuous monitoring of vital signs and cardiac arrhythmias, enabling proactive patient management. While both leverage AI in cardiology, they address different stages of care: AI-CVD for imaging-based risk assessment and VitalPatch for continuous physiological monitoring.

Choose AI-CVD if…

Choose AI-CVD if your primary objective is to opportunistically screen for hidden cardiovascular and multisystem disease risks using existing CT scans, without requiring additional imaging, radiation, or workflow disruption. This platform is ideal for leveraging previously acquired radiological data to identify at-risk individuals for conditions like coronary artery calcium and cardiac chamber abnormalities, facilitating early detection and intervention.

View AI-CVD →

Choose VitalConnect VitalPatch if…

Choose VitalConnect VitalPatch if you need real-time, continuous monitoring of vital signs and cardiac arrhythmias for patients in either an in-hospital or remote patient monitoring (RPM) setting. This wearable biosensor is best suited for scenarios demanding constant oversight of patient physiological data, such as post-operative recovery, managing chronic cardiac conditions, or detecting acute cardiac events over a 7-day period.

View VitalConnect VitalPatch →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AI-CVD VitalConnect VitalPatch
Pricing Unknown Contact for pricing
Deployment Unknown Cloud-based with wearable biosensor and patient-carried relay devices (VistaPhone/VistaTablet).
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AI-CVD

AI-CVD leverages existing CT scans, minimizing workflow disruption and patient burden by not requiring additional imaging or patient-specific actions for data collection. In contrast, VitalPatch requires patients to wear a device and carry relay devices, introducing more patient interaction and potential compliance challenges.

Clinical Value

AI-CVD

While both are FDA-cleared and offer significant clinical value, AI-CVD provides a broader, opportunistic screening for a wider range of hidden cardiovascular and multisystem disease risks from existing CT scans, potentially impacting a larger population for early detection and prevention. VitalPatch focuses on real-time monitoring of vital signs and arrhythmias, which is crucial for acute management but narrower in its proactive screening scope.

Pricing & Value

VitalConnect VitalPatch

VitalConnect VitalPatch offers greater transparency regarding its pricing model, explicitly stating it's subscription-based with monthly fees tied to clinical services and is widely covered by Medicare and private insurers. This provides healthcare organizations with a clearer understanding of potential costs and reimbursement pathways. AI-CVD only states 'contact for pricing' without further details.

Enterprise Readiness

AI-CVD

Both are cloud-based and FDA-cleared. However, AI-CVD integrates seamlessly into existing CT imaging workflows, minimizing additional operational overhead for device management and patient compliance within an enterprise setting. VitalPatch, while HIPAA compliant, requires the logistical management of physical wearable devices and patient-carried relays, which adds complexity for large-scale enterprise deployment.

Innovation

Tie

Both tools demonstrate significant and distinct innovations. AI-CVD's innovation lies in its ability to opportunistically screen for a broad spectrum of hidden diseases from existing CT scans, maximizing the value of routine imaging. VitalPatch's innovation is in its comprehensive, real-time wearable biosensor technology for continuous patient monitoring and AI-powered arrhythmia detection, pushing the boundaries of remote care.

Support & Docs

VitalConnect VitalPatch

VitalConnect VitalPatch clearly outlines a comprehensive support ecosystem with dedicated teams for various needs (customer service, technical support, billing, inventory) and provides extensive documentation for both patients and healthcare providers. This level of detailed and accessible support is not evident for AI-CVD based on available information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AI-CVD VitalConnect VitalPatch
Name AI-CVD VitalConnect VitalPatch
Company HeartLung Corporation VitalConnect
Description AI-CVD® is an FDA-cleared, AI-powered quantitative imaging platform from HeartLung Corporation that performs opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks. VitalConnect's VitalPatch is a wearable biosensor and cloud-based platform for real-time, continuous monitoring of vital signs and cardiac arrhythmias for healthcare professionals, enabling remote patient monitoring and in-hospital care.
Categories Cardiology AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Pulmonology, Radiology Cardiology, Critical Care, Emergency Medicine
Key Features Automated CT-derived anatomical and density-based measurements, Opportunistic screening from existing chest and abdominal CT scans, No additional imaging, radiation, contrast, or workflow disruption, Coronary Artery Calcium (CAC) scoring, Aortic wall, aortic valve, and mitral valve calcium analysis, Cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle), Epicardial fat volumetry, Aorta and pulmonary artery sizing Wearable biosensor (VitalPatch) for continuous monitoring, Real-time streaming of up to 11 vital signs, including live ECG, Detection of 21 cardiac arrhythmias using AI algorithms, Cloud-based platform (VitalCloud, VistaCenter) for data storage and analysis, Patient-carried relay devices (VistaPhone, VistaTablet) with VistaPoint application, Water-resistant (IPX7) for daily activities, 7-day (168-hour) continuous wear period per biosensor, Medical-grade, hypoallergenic adhesive with low skin irritation

Videos

Demos, reviews, and walkthroughs featuring AI-CVD and VitalConnect VitalPatch.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AI-CVD utilizes existing chest and abdominal CT scans to perform opportunistic screening for cardiovascular and multisystem diseases. In contrast, VitalConnect VitalPatch employs a wearable biosensor that continuously monitors vital signs and cardiac arrhythmias directly from the patient.
AI-CVD is designed for early detection and risk assessment through the analysis of existing imaging data, identifying hidden health risks without additional procedures. VitalConnect VitalPatch focuses on real-time, continuous patient monitoring for both remote and in-hospital settings, enabling ongoing management of vital signs and cardiac rhythms.
AI-CVD integrates by analyzing existing CT scans, requiring no additional imaging, radiation, contrast, or disruption to current workflows. VitalConnect VitalPatch involves patients wearing a biosensor and potentially carrying relay devices, which requires patient compliance and management within the monitoring workflow.
AI-CVD provides automated CT-derived measurements such as Coronary Artery Calcium (CAC) scoring, aortic/mitral valve calcium analysis, and cardiac chamber volumetry. VitalConnect VitalPatch offers real-time streaming of up to 11 vital signs, live ECG, and detection of 21 cardiac arrhythmias using AI algorithms.
VitalConnect VitalPatch's subscription-based services are widely covered by Medicare and private insurers, with monthly fees tied to clinical services. For AI-CVD, pricing details and insurance coverage specifics would require direct contact with the vendor.

Backers

Who funded each tool's parent company.

VitalConnect VitalPatch

AI Tool Finder
AI-powered search. Results may not be comprehensive.